News Chart Madrigal Pharmaceuticals, Inc.

Equities

MDGL

US5588681057

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-13 pm EDT			5-day change	1st Jan Change
211.3 ^USD	+2.96%		-10.29%	-8.67%

May. 10	B. Riley Cuts Madrigal Pharmaceuticals' Price Target to $200 From $270, Keeps Neutral Rating	MT
May. 09	UBS Adjusts Price Target on Madrigal Pharmaceuticals to $411 From $410, Maintains Buy Rating	MT

cf50d502ebad23c475.sUnkKbkxayvu9_YyEBw5JwJ55l5RowEyCCVmot0tMDk.2RuiX9UJHVGjw4MKYn5dTVcsnBQQ91Z_TFxRzqd6RA3AZKpm5nlaYaedrw~7a521ef17f9d12824e67c8ab5a7de895